Skip to main content
RaQualia Pharma Inc. logo

RaQualia Pharma Inc. — Investor Relations & Filings

Ticker · 4579 ISIN · JP3967150008 T Professional, scientific and technical activities
Filings indexed 89 across all filing types
Latest filing 2018-03-30 Annual Report
Country JP Japan
Listing T 4579

About RaQualia Pharma Inc.

https://www.raqualia.com/en/index.html

RaQualia Pharma Inc. is a research and development-focused pharmaceutical company that specializes in the discovery and development of innovative small molecule compounds. The company's primary activities involve conducting exploratory research to identify novel drug candidates and advancing them through preclinical and clinical studies. Its business model centers on creating value by out-licensing the intellectual property of these compounds to other pharmaceutical companies for final development and commercialization. A key product originating from its research is tegoprazan (K-CAB®), a potassium-competitive acid blocker used for treating gastroesophageal reflux disease and other acid-related conditions.

Recent filings

Filing Released Lang Actions
有価証券報告書-第10期(平成29年1月1日-平成29年12月31日)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed by RaQualia Pharma Inc. with the Tokai Local Finance Bureau. It covers the fiscal year from January 1, 2017, to December 31, 2017. This is the Japanese equivalent of a 10-K, containing comprehensive financial statements, business descriptions, and management analysis. It is a full annual report, not an announcement or a summary. FY 2017
2018-03-30 Japanese
四半期報告書-第10期第3四半期(2017/07/01-2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第3四半期報告書) for RaQualia Pharma Inc. covering the period from January 1, 2017, to September 30, 2017. It contains detailed financial statements (Balance Sheet, Income Statement, Cash Flow Statement) and management analysis, which are characteristic of an Interim/Quarterly Report. It is not an announcement of a report, as it contains the full financial data. 9M 2017
2017-11-10 Japanese
訂正四半期報告書-第10期第2四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for RaQualia Pharma Inc. covering the second quarter of the 10th fiscal year (April 1, 2017, to June 30, 2017). It contains detailed financial statements, management analysis, and business status updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2017
2017-11-10 Japanese
四半期報告書-第10期第2四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for RaQualia Pharma Inc., covering the period from April 1, 2017, to June 30, 2017. It contains detailed financial statements, management analysis of financial results, and business operations, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2017
2017-08-10 Japanese
四半期報告書-第10期第1四半期(2017/01/01-2017/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for RaQualia Pharma Inc., covering the period from January 1, 2017, to March 31, 2017. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management's analysis of the business and financial condition. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2017
2017-05-15 Japanese
有価証券報告書-第9期(2016/01/01-2016/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) for RaQualia Pharma Inc. for the fiscal year ending December 31, 2016. This is the Japanese equivalent of a 10-K, which is a comprehensive annual report containing financial statements, business descriptions, and management analysis. It is not an announcement or a summary, but the full regulatory filing itself. FY 2016
2017-03-31 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.